D-Arginine is used to attenuate arginase expression upregulation, oxidative stress, endothelial dysfunction, and advanced glycation end-product formation induced by methylglyoxal and high glucose. Its effects can occur via an endothelial nitric oxide synthase (eNOS)-independent mechanism.